Skip to main content

NEA Approved Features

Peter Sonnenreich, Contributing Writer
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
Jonmichael W. Samsel, BS, Courtney E. Heron, BS, Steven R. Feldman, MD, PhD, Sarah L. Taylor, MD, MPH
Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics, and disease severity of eczema.
Jessica E. Payne, BS, Rima I. Ghamrawi, BS, Lindsay C. Strowd, MD
Atopic dermatitis can have a significant effect on the quality of life of all patients, especially for the children and adolescents who are primarily affected by the disease.
Lauren Mateja, Managing Editor
The Centers for Disease Control and Prevention and World Health Organization advise that hand washing is critical to slowing the spread of infection, but patients with dermatitis may need further guidance from their dermatologists.
Lauren Mateja, Managing Editor
A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.
Melissa Weiss, Associate Editor
Patients with eczema often wonder if their diet can affect their disease severity. In an interview with The Dermatologist, Aaron Drucker, MD, discussed his study on the role of gluten as a risk factor for inflammatory disease severity.
Esther A. Balogh, MD, Elnara Muradova, MS, Lindsay C. Strowd, MD, FAAD
Genetic polymorphisms and defects are commonly found in patients with atopic dermatitis. A more personalized therapy that considers individual genetics and pathogenesis may provide a more effective treatment approach.
Rachel Shireen Golpanian, BA, Kayla Fourzali, MS, Hong Liang Tey, MD, Gil Yosipovitch, MD
Diagnosis of atopic dermatitis in skin of color and in various age groups can be challenging. Understanding the differences in presentation can help with implementing appropriate treatment sooner.
Melissa Weiss, Associate Editor
In an interview with The Dermatologist, Andrew F. Alexis, MD, reviewed important considerations for diagnosing and treating atopic dermatitis in patients with skin of color.
Back to Top